Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80–150 cc)
- 25 July 2018
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 30 (5) , 209-214
Abstract
Between September and December 2017, 82 men with moderate-to-severe lower urinary tract symptoms due to benign prostatic hyperplasia LUTS/BPH and prostate volume of 80–150 cc underwent Aquablation in a prospective multicenter clinical trial in the United States. Baseline patient and clinical demographics and standardized postoperative parameters were collected and tabulated in a central independently monitored database. Adverse events through 3 months were adjudicated by an independent clinical events committee. Mean pre-treatment prostate volume was 108 ± 21.1 cc. Mean operative time was 38.2 ± 14.4 min and mean Aquablation resection time was 7.7 ± 3.3 min. Additional electrocautery for hemostasis was not needed in any patient following Aquablation. The average length of stay following the procedure was 1.6 ± 1.0 days. Mean pre- and 3 months post-treatment IPSS scores were 23.7 ± 6.4 and 7.1 ± 5.1, –16.6, p < 0.01. Mean pre- and 3 months post-treatment Qmax were 9.2 ± 3.3 ml/s and 19.5 ± 13 ml/s, + 10.8 ml/s, p < 0.01. Mean pre- and 3 months post-treatment post-void residuals were 120.6 ± 119.1 cc and 50.6 ± 61.6 cc, –72.0 cc, p < 0.01. The observed Clavien-Dindo grade 2 or higher event rate at 3 months was 34.1%. Aquablation is a safe and effective treatment option for men with large prostates (80–150 cc) suffering from LUTS/BPH.Keywords
This publication has 22 references indexed in Scilit:
- National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative OutcomesUrology, 2015
- Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (Ho LEP )BJU International, 2015
- Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and OutcomesJournal of Urology, 2015
- 180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial—The GOLIATH StudyEuropean Urology, 2014
- 180 W vs 120 W Lithium Triborate Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia: A Global, Multicenter Comparative Analysis of Perioperative Treatment ParametersUrology, 2013
- Update on AUA Guideline on the Management of Benign Prostatic HyperplasiaJournal of Urology, 2011
- Complications and Early Postoperative Outcome After Open Prostatectomy in Patients With Benign Prostatic Enlargement: Results of a Prospective Multicenter StudyJournal of Urology, 2007
- UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2005
- TRANSURETHRAL HOLMIUM LASER ENUCLEATION OF THE PROSTATE VERSUS TRANSURETHRAL ELECTROCAUTERY RESECTION OF THE PROSTATE: A RANDOMIZED PROSPECTIVE TRIAL IN 200 PATIENTSJournal of Urology, 2004
- A Randomized Trial Comparing Holmium Laser Enucleation of the Prostate with Transurethral Resection of the Prostate for the Treatment of Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia in Large Glands (40 to 200 Grams)Journal of Urology, 2003